RGA Study Predicts GLP-1s Will Lower US Mortality Rate by 3.5% in the Next Two Decades
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 11 2025
0mins
Should l Buy RGA?
Source: Newsfilter
Potential Impact on Mortality: By 2045, incretin-based drugs like GLP-1s could reduce mortality in the US by 3.5% under a central scenario, with variations of 8.8% in an optimistic scenario and 1.0% in a pessimistic scenario; similar reductions are expected in the UK, Canada, and Hong Kong.
Age-Related Variations: The greatest mortality improvements are anticipated in individuals aged 45-59, while those aged 85 and older are expected to see the least reduction.
Morbidity and Insured Groups: While there may be positive reductions in cancer incidence, insured groups are likely to experience lower mortality and morbidity reductions compared to the general population due to lower average BMI.
Future of Incretin-Based Therapies: The ongoing investigation into incretin-based therapies for various medical conditions, along with the potential for cost reductions through competition and generics, suggests a promising future for these drugs in improving public health outcomes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RGA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RGA
Wall Street analysts forecast RGA stock price to rise
7 Analyst Rating
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 212.840
Low
208.00
Averages
242.33
High
275.00
Current: 212.840
Low
208.00
Averages
242.33
High
275.00
About RGA
Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
RGA Appoints New Executive Vice President of Investments
- Executive Appointment: RGA announced that Jayson Bronchetti will join as Executive Vice President of Investments on March 2, 2026, overseeing the company's investment management strategy and reporting to CEO Tony Cheng, which is expected to enhance the firm's investment decision-making capabilities and market competitiveness.
- Extensive Experience: At Lincoln Financial, Bronchetti managed over $300 billion in assets and successfully guided a $150 billion variable product hedging program, demonstrating his strong background in asset management and risk oversight, which will be crucial for RGA's investment strategies.
- Strategic Leadership: He will succeed Leslie Barbi, who has led RGA's investment function since 2020, and his strategic vision and industry knowledge are anticipated to bring new growth opportunities to RGA, further strengthening the company's market position.
- Educational Background: Bronchetti holds a bachelor's degree in finance from Miami University and completed the Executive Development Program at the Wharton School, providing him with a solid financial foundation and industry network that will support RGA's long-term value creation.
See More
RGA Prices $400M Debt Offering to Support Corporate Growth
- Debt Offering Size: Reinsurance Group of America (RGA) successfully priced a $400 million offering of 6.375% fixed-rate reset subordinated debentures due 2056, demonstrating the company's strong financing capability in the capital markets.
- Bond Terms Details: The bonds are issued at 100% of face value, featuring a fixed coupon rate of 6.375% payable semiannually, which will provide the company with a stable cash inflow to support its operations and investments.
- Planned Use of Proceeds: RGA intends to utilize the net proceeds from this offering for general corporate purposes, including potential refinancing of debt obligations, which will help optimize its capital structure and reduce financial costs.
- Issuance Timeline: The bond offering is expected to close around March 3, 2026, indicating the company's strategic financial planning for the coming years aimed at enhancing its market competitiveness and financial flexibility.
See More
RGA Prices $400 Million Fixed-Rate Reset Subordinated Debentures
- Bond Offering Size: RGA has announced the pricing of $400 million in 6.375% Fixed-Rate Reset Subordinated Debentures due 2056, with an issue price of 100%, expected to close on March 3, 2026, indicating strong capital market financing capabilities.
- Clear Use of Proceeds: The net proceeds from this bond offering will be used for general corporate purposes, including potential debt refinancing, aimed at optimizing the company's capital structure and enhancing financial flexibility.
- Strong Underwriter Lineup: The offering is backed by a robust team of joint book-running managers including BofA Securities, J.P. Morgan, U.S. Bancorp Investments, and Wells Fargo Securities, reflecting market confidence and support for RGA.
- Compliance and Transparency: This offering is conducted under an SEC registration statement, ensuring that investors can access relevant prospectuses via the SEC website, demonstrating RGA's commitment to compliance and transparency.
See More
RGA Prices $400 Million Fixed-Rate Reset Debentures
- Bond Issuance Size: RGA announced the pricing of $400 million in 6.375% Fixed-Rate Reset Debentures due 2056, with an issue price of 100%, expected to close on March 3, 2026, which will provide the company with a stable funding source for future growth.
- Clear Use of Proceeds: The net proceeds from this offering will be used for general corporate purposes, including potential debt refinancing, indicating RGA's strategic intent to optimize its capital structure and reduce financial costs.
- Strong Underwriting Team: Renowned financial institutions such as BofA Securities, J.P. Morgan, U.S. Bancorp Investments, and Wells Fargo Securities are acting as joint book-running managers for the offering, reflecting market confidence and support for RGA's debt instruments.
- Regulatory Transparency: The offering complies with SEC registration statements, ensuring that investors can access relevant prospectuses via the SEC website, thereby enhancing investor trust in RGA's transparency and compliance.
See More
RGA Reinsurance Company Affirms A+ Rating
- Rating Affirmation: AM Best has affirmed RGA Reinsurance Company and its subsidiaries' Financial Strength Rating of A+ (Superior) and Long-Term Issuer Credit Ratings of 'aa-' (Superior), reflecting their strong balance sheet and operational performance.
- Capital Adequacy: RGA's risk-adjusted capitalization is assessed at the strongest level, indicating compliance with AM Best's standards for financial leverage and liquidity, ensuring a stable financial foundation.
- Market Position: RGA maintains a strong market position in the U.S. and international markets, with approximately half of its revenue derived from international operations, demonstrating the potential for global business expansion as overall premiums have steadily increased in recent years.
- Risk Management: RGA's enterprise risk management framework is continuously enhanced, integrating stress testing and risk monitoring to improve its strategic and operational risk management capabilities, although earnings volatility persists in certain business segments.
See More
RGA Reports Record Q4 2025 Earnings and Strategic Shift
- Record EPS Achievement: RGA reported a record operating EPS of $7.75 for Q4 2025, significantly up from $6.37 in Q3, marking the second consecutive quarter of record earnings, which reflects strong financial performance and market confidence.
- Capital Deployment and Buybacks: The company deployed $2.5 billion into in-force transactions for the full year, with $98 million in Q4 alone, and repurchased $50 million in shares during the quarter, indicating RGA's commitment to maintaining a robust capital base while actively returning value to shareholders.
- Strategic Business Exit: RGA announced its decision to exit the group health care business, which is expected to primarily impact results in 2027, reflecting a strategic focus on more attractive business lines following a comprehensive review of its operations.
- Future Outlook and Growth Targets: Management reiterated its targets of 8% to 10% annual EPS growth and a 13% to 15% return on equity, with an expected capital deployment of around $1.5 billion in 2026, demonstrating confidence in future growth and clarity in strategic planning.
See More
RGA Appoints New Executive Vice President of Investments
- Executive Appointment: RGA announced that Jayson Bronchetti will join as Executive Vice President of Investments on March 2, 2026, overseeing the company's investment management strategy and reporting to CEO Tony Cheng, which is expected to enhance the firm's investment decision-making capabilities and market competitiveness.
- Extensive Experience: At Lincoln Financial, Bronchetti managed over $300 billion in assets and successfully guided a $150 billion variable product hedging program, demonstrating his strong background in asset management and risk oversight, which will be crucial for RGA's investment strategies.
- Strategic Leadership: He will succeed Leslie Barbi, who has led RGA's investment function since 2020, and his strategic vision and industry knowledge are anticipated to bring new growth opportunities to RGA, further strengthening the company's market position.
- Educational Background: Bronchetti holds a bachelor's degree in finance from Miami University and completed the Executive Development Program at the Wharton School, providing him with a solid financial foundation and industry network that will support RGA's long-term value creation.
See More
RGA Prices $400M Debt Offering to Support Corporate Growth
- Debt Offering Size: Reinsurance Group of America (RGA) successfully priced a $400 million offering of 6.375% fixed-rate reset subordinated debentures due 2056, demonstrating the company's strong financing capability in the capital markets.
- Bond Terms Details: The bonds are issued at 100% of face value, featuring a fixed coupon rate of 6.375% payable semiannually, which will provide the company with a stable cash inflow to support its operations and investments.
- Planned Use of Proceeds: RGA intends to utilize the net proceeds from this offering for general corporate purposes, including potential refinancing of debt obligations, which will help optimize its capital structure and reduce financial costs.
- Issuance Timeline: The bond offering is expected to close around March 3, 2026, indicating the company's strategic financial planning for the coming years aimed at enhancing its market competitiveness and financial flexibility.
See More
RGA Prices $400 Million Fixed-Rate Reset Subordinated Debentures
- Bond Offering Size: RGA has announced the pricing of $400 million in 6.375% Fixed-Rate Reset Subordinated Debentures due 2056, with an issue price of 100%, expected to close on March 3, 2026, indicating strong capital market financing capabilities.
- Clear Use of Proceeds: The net proceeds from this bond offering will be used for general corporate purposes, including potential debt refinancing, aimed at optimizing the company's capital structure and enhancing financial flexibility.
- Strong Underwriter Lineup: The offering is backed by a robust team of joint book-running managers including BofA Securities, J.P. Morgan, U.S. Bancorp Investments, and Wells Fargo Securities, reflecting market confidence and support for RGA.
- Compliance and Transparency: This offering is conducted under an SEC registration statement, ensuring that investors can access relevant prospectuses via the SEC website, demonstrating RGA's commitment to compliance and transparency.
See More
RGA Prices $400 Million Fixed-Rate Reset Debentures
- Bond Issuance Size: RGA announced the pricing of $400 million in 6.375% Fixed-Rate Reset Debentures due 2056, with an issue price of 100%, expected to close on March 3, 2026, which will provide the company with a stable funding source for future growth.
- Clear Use of Proceeds: The net proceeds from this offering will be used for general corporate purposes, including potential debt refinancing, indicating RGA's strategic intent to optimize its capital structure and reduce financial costs.
- Strong Underwriting Team: Renowned financial institutions such as BofA Securities, J.P. Morgan, U.S. Bancorp Investments, and Wells Fargo Securities are acting as joint book-running managers for the offering, reflecting market confidence and support for RGA's debt instruments.
- Regulatory Transparency: The offering complies with SEC registration statements, ensuring that investors can access relevant prospectuses via the SEC website, thereby enhancing investor trust in RGA's transparency and compliance.
See More
RGA Reinsurance Company Affirms A+ Rating
- Rating Affirmation: AM Best has affirmed RGA Reinsurance Company and its subsidiaries' Financial Strength Rating of A+ (Superior) and Long-Term Issuer Credit Ratings of 'aa-' (Superior), reflecting their strong balance sheet and operational performance.
- Capital Adequacy: RGA's risk-adjusted capitalization is assessed at the strongest level, indicating compliance with AM Best's standards for financial leverage and liquidity, ensuring a stable financial foundation.
- Market Position: RGA maintains a strong market position in the U.S. and international markets, with approximately half of its revenue derived from international operations, demonstrating the potential for global business expansion as overall premiums have steadily increased in recent years.
- Risk Management: RGA's enterprise risk management framework is continuously enhanced, integrating stress testing and risk monitoring to improve its strategic and operational risk management capabilities, although earnings volatility persists in certain business segments.
See More
RGA Reports Record Q4 2025 Earnings and Strategic Shift
- Record EPS Achievement: RGA reported a record operating EPS of $7.75 for Q4 2025, significantly up from $6.37 in Q3, marking the second consecutive quarter of record earnings, which reflects strong financial performance and market confidence.
- Capital Deployment and Buybacks: The company deployed $2.5 billion into in-force transactions for the full year, with $98 million in Q4 alone, and repurchased $50 million in shares during the quarter, indicating RGA's commitment to maintaining a robust capital base while actively returning value to shareholders.
- Strategic Business Exit: RGA announced its decision to exit the group health care business, which is expected to primarily impact results in 2027, reflecting a strategic focus on more attractive business lines following a comprehensive review of its operations.
- Future Outlook and Growth Targets: Management reiterated its targets of 8% to 10% annual EPS growth and a 13% to 15% return on equity, with an expected capital deployment of around $1.5 billion in 2026, demonstrating confidence in future growth and clarity in strategic planning.
See More
